Renata Kupská

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

Luděk Pour, Henrieta Grešlíková, Renata Kupská et al. · Haematologica · 2013 · 183 citations · Full text

Medicine, Hematology, Oncology +14

Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy

Pavel Němec, Zuzana Zemanová, Henrieta Grešlíková et al. · Biology of Blood and Marrow Transplantation · 2009 · 70 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Cytogenetics in multiple myeloma patients progressing into extramedullary disease

Lenka Bešše, Lenka Sedlaříková, Henrieta Grešlíková et al. · European Journal Of Haematology · 2015 · 56 citations

Medicine, Hematology, Oncology +15

Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience

Jan Smetana, Jan Fröhlich, Romana Zaoralová et al. · BioMed Research International · 2014 · 26 citations · Full text

Life Sciences, Genetics, Hematology +17

Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib

Jan Smetana, Kristina Beránková, Romana Zaoralová et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 24 citations · Full text

Medicine, Genetics, Molecular Genetics +12